ACW -
99.6% Failure rate on Alzheimer's trials (The Odds are
NOT in your favor)
Phase II Trials = FAIL - ongoing trials are up against a 99.6% failure rate & upon next results one would not wish to be holding, no matter how much dollars they have in the kitty
Holders relying on a 'proposed' R&D Rebate, the ultimate success of ASX listed stocks receiving R&D rebates and having future success are minimal in the least.
Worth CASH Backing atm, and that stands at around a $10-11 Million MC
View attachment 1546195
